题名 | First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study. |
链接 | http://annonc.oxfordjournals.org/content/26/9/1883.long |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |